{
  "name": "Dynamic Biotechnology & Genome ETF",
  "ticker": "PBE",
  "Inception": "6/23/2005",
  "Gross Exp. Ratio": "0.57%",
  "YTD": "1.3",
  "1Yr": "19.46",
  "3Yr": "4.29",
  "5Yr": "4.68",
  "10Yr": "11.61",
  "Since Incept.": "9.46",
  "Category": "Multi Factor",
  "SubCategory": "Intellidex Industries",
  "infer": "invesco",
  "issuer": "Invesco",
  "website": "https://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=PBE",
  "holdingDataSource": {
    "url": "https://www.invesco.com/us/financial-products/etfs/holdings/main/holdings/0?audienceType=Investor&action=download&ticker=PBE",
    "fileExt": "csv",
    "transform": "invesco"
  },
  "holdings": [
    {
      "ticker": "PACB",
      "name": "Pacific Biosciences of California Inc",
      "percent": "5.679"
    },
    {
      "ticker": "QGEN",
      "name": "QIAGEN NV",
      "percent": "4.907"
    },
    {
      "ticker": "BIIB",
      "name": "Biogen Inc",
      "percent": "4.878"
    },
    {
      "ticker": "VRTX",
      "name": "Vertex Pharmaceuticals Inc",
      "percent": "4.664"
    },
    {
      "ticker": "GILD",
      "name": "Gilead Sciences Inc",
      "percent": "4.605"
    },
    {
      "ticker": "REGN",
      "name": "Regeneron Pharmaceuticals Inc",
      "percent": "4.605"
    },
    {
      "ticker": "ILMN",
      "name": "Illumina Inc",
      "percent": "4.431"
    },
    {
      "ticker": "AMGN",
      "name": "Amgen Inc",
      "percent": "4.431"
    },
    {
      "ticker": "NBIX",
      "name": "Neurocrine Biosciences Inc",
      "percent": "4.171"
    },
    {
      "ticker": "CDNA",
      "name": "CareDx Inc",
      "percent": "3.872"
    },
    {
      "ticker": "FATE",
      "name": "Fate Therapeutics Inc",
      "percent": "3.484"
    },
    {
      "ticker": "INSM",
      "name": "Insmed Inc",
      "percent": "3.300"
    },
    {
      "ticker": "XLRN",
      "name": "Acceleron Pharma Inc",
      "percent": "3.197"
    },
    {
      "ticker": "OPK",
      "name": "OPKO Health Inc",
      "percent": "3.161"
    },
    {
      "ticker": "NTLA",
      "name": "Intellia Therapeutics Inc",
      "percent": "3.103"
    },
    {
      "ticker": "FOLD",
      "name": "Amicus Therapeutics Inc",
      "percent": "2.936"
    },
    {
      "ticker": "CRSP",
      "name": "CRISPR Therapeutics AG",
      "percent": "2.914"
    },
    {
      "ticker": "FGEN",
      "name": "FibroGen Inc",
      "percent": "2.876"
    },
    {
      "ticker": "EXEL",
      "name": "Exelixis Inc",
      "percent": "2.785"
    },
    {
      "ticker": "DRNA",
      "name": "Dicerna Pharmaceuticals Inc",
      "percent": "2.762"
    },
    {
      "ticker": "ALKS",
      "name": "Alkermes PLC",
      "percent": "2.706"
    },
    {
      "ticker": "SGMO",
      "name": "Sangamo Therapeutics Inc",
      "percent": "2.683"
    },
    {
      "ticker": "UTHR",
      "name": "United Therapeutics Corp",
      "percent": "2.675"
    },
    {
      "ticker": "HALO",
      "name": "Halozyme Therapeutics Inc",
      "percent": "2.644"
    },
    {
      "ticker": "CHRS",
      "name": "Coherus Biosciences Inc",
      "percent": "2.477"
    },
    {
      "ticker": "IRWD",
      "name": "Ironwood Pharmaceuticals Inc",
      "percent": "2.465"
    },
    {
      "ticker": "NKTR",
      "name": "Nektar Therapeutics",
      "percent": "2.352"
    },
    {
      "ticker": "EBS",
      "name": "Emergent BioSolutions Inc",
      "percent": "2.123"
    },
    {
      "ticker": "FLDM",
      "name": "Fluidigm Corp",
      "percent": "2.109"
    },
    {
      "ticker": "AKBA",
      "name": "Akebia Therapeutics Inc",
      "percent": "0.904"
    },
    {
      "ticker": "AGPXX",
      "name": "STIT - Government & Agency Portfolio",
      "percent": "0.103"
    }
  ]
}